| GENE Snapshot | |
|---|---|
| Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help clinicians monitor women's health in Australia and the United States. The company is headquartered in Fitzroy, Australia. | |
| VALUATION DATA | |
| Market Capitalization | $10,661,000 | Price to Sales | 0.00 |
| Earnings per Share | $-0.1500 |
| PE Ratio | None |
| PRICE DATA | |
| Most Recent Close | $2.2500 |
| 52 Week High | $1.29 |
| 52 Week Low | $4.08 |
| 50-Day Moving Average | $1.298 |
| 200-Day Moving Average | $-0.913 |
| All data are from Alpha Vantage as of today. For more infomation on GENE see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search